0000950170-25-048893.txt : 20250402 0000950170-25-048893.hdr.sgml : 20250402 20250402085628 ACCESSION NUMBER: 0000950170-25-048893 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250402 DATE AS OF CHANGE: 20250402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Connealy Pamela Ann CENTRAL INDEX KEY: 0001796310 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40881 FILM NUMBER: 25802315 MAIL ADDRESS: STREET 1: 320 W 37TH STREET, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER NAME: FORMER CONFORMED NAME: Yanchik Connealy Pamela DATE OF NAME CHANGE: 20191209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pyxis Oncology, Inc. CENTRAL INDEX KEY: 0001782223 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 831160910 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 HARRISON AVENUE CITY: BOSTON STATE: MA ZIP: 02118 BUSINESS PHONE: (617) 221-9059 MAIL ADDRESS: STREET 1: 321 HARRISON AVENUE CITY: BOSTON STATE: MA ZIP: 02118 4 1 ownership.xml 4 X0508 4 2025-03-31 false 0001782223 Pyxis Oncology, Inc. PYXS 0001796310 Connealy Pamela Ann C/O PYXIS ONCOLOGY, INC. 321 HARRISON AVENUE, 11TH FL. SUITE 1 BOSTON MA 02118 false true false false CFO & COO false Stock Option (Right to Buy) 0.98 2025-03-31 4 A false 414163 0.98 A 2035-03-31 Common Stock 414163 414163 D The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 31, 2025 and the remainder vesting in 36 equal monthly installments thereafter subject to the reporting person's continued emmployment through the applicable vesting date. /s/ Pamela Connealy 2025-04-02